Amgen Inc.

David W Gibbs (Director) reports AMGN insider transactions

4AMGNFiled Nov 9, 2026, 7:44 PM ET· Period Nov 6, 2026

AI-generated summary

Director David W Gibbs received 278 shares as a grant on November 6, 2026. Following this transaction, they directly hold 278 shares of Common Stock.

Key facts

Date	Transaction	Shares	Price	Value	Held after	Ownership
Nov 6, 2026	A · grantFootnotes F1	+278	$0.00	$0.00	278	Direct

Footnotes

F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

Not investment advice. Summaries can contain errors; the SEC filing is the official record.